{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:46:11Z","timestamp":1788050771004,"version":"build-2784847793"},"reference-count":29,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1254\/jphs.12089fp","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T22:44:25Z","timestamp":1345675465000},"page":"36-44","source":"Crossref","is-referenced-by-count":35,"title":["Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice"],"prefix":"10.1254","volume":"120","author":[{"given":"Atsuo","family":"Tahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yokono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamajuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hayashizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10761"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Idris I, Donnelly R. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug. Diabetes Obes Metab. 2009;11:79&ndash;88.","DOI":"10.1111\/j.1463-1326.2008.00982.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Wright EM, Turk E. The sodium\/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510&ndash;518.","DOI":"10.1007\/s00424-003-1063-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Pajor AM, Wright EM. Cloning and functional expression of a mammalian Na+\/nucleoside cotransporter. A member of the SGLT family. J Biol Chem. 1992;267:3557&ndash;3560.","DOI":"10.1016\/S0021-9258(19)50557-9"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1038\/350354a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wells RG, Pajor AM, Kanai Y, Turk E, Wright EM, Hediger MA. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol. 1992;263:F459&ndash;F465.","DOI":"10.1152\/ajprenal.1992.263.3.F459"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 van den Heuvel LP, Assink K, Willemsen M, Monnens L. Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2). Hum Genet. 2002;111:544&ndash;547.","DOI":"10.1007\/s00439-002-0820-5"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90120-2"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112981"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115031"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.532"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.9.1794"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Han S, Hagan DL, Taylor JR, Xin L, Meng W, Biller SA, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes. 2008;57:1723&ndash;1729.","DOI":"10.2337\/db07-1472"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-011-0713-z"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1087167"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Hayakawa M, Shibasaki M. Evaluation of the antidiabetic effects of dipeptidyl peptidase-IV inhibitor ASP8497 in streptozotocin-nicotinamide-induced mildly diabetic mice. Pharmacology. 2009;83:177&ndash;187.","DOI":"10.1159\/000196813"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Fujimori Y, Katsuno K, Ojima K, Nakashima I, Nakano S, Ishikawa-Takemura Y, et al. Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats. Eur J Pharmacol. 2009;609:148&ndash;154.","DOI":"10.1016\/j.ejphar.2009.03.007"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1021\/jm990175n"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 van den Arend IJ, Stolk RP, Krans HM, Grobbee DE, Schrijvers AJ. Management of type 2 diabetes: a challenge for patient and physician. Patient Educ Couns. 2000;40:187&ndash;194.","DOI":"10.1016\/S0738-3991(99)00067-1"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.21.2005"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610100104"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Matsuyama-Yokono A, Tahara A, Nakano R, Someya Y, Shiraki K, Hayakawa M, et al. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice. Metabolism. 2009;58:379&ndash;386.","DOI":"10.1016\/j.metabol.2008.10.012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hosokawa YA, Leahy JL. Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats. Diabetes. 1997;46:808&ndash;813.","DOI":"10.2337\/diab.46.5.808"},{"key":"25","unstructured":"25 Leahy JL. Beta-cell dysfunction with chronic hyperglycemia: &ldquo;overworked beta-cell&rdquo; hypothesis. Diabetes Rev. 1996;4:298&ndash;319."},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00534.x"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.10.2001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Zhang L, Feng Y, List J, Kasichayanula S, Pfister M. Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight. Diabetes Obes Metab. 2010;12:510&ndash;516.","DOI":"10.1111\/j.1463-1326.2010.01216.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Devenny JJ, Godonis HE, Harvey SJ, Rooney S, Cullen MJ, Pelleymounter MA. Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. Obesity (Silver Spring). 2012;20:1645&ndash;1652.","DOI":"10.1038\/oby.2012.59"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T04:47:33Z","timestamp":1643258853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/120\/1\/120_12089FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.12089fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}